Class information for:
Level 1: A33 ANTIGEN//ADHESION REGULATING MOLECULE 1//ADRM1

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
35662 94 36.0 87%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
416 3       NEUROENDOCRINE TUMORS//CARCINOID//SMALL CELL CARCINOMA 28897
808 2             RADIOIMMUNOTHERAPY//NUCLEAR MEDICINE AND BIOLOGY//ANTIBODY DRUG CONJUGATE 12023
35662 1                   A33 ANTIGEN//ADHESION REGULATING MOLECULE 1//ADRM1 94

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 A33 ANTIGEN authKW 1353528 5% 83% 5
2 ADHESION REGULATING MOLECULE 1 authKW 974542 3% 100% 3
3 ADRM1 authKW 974542 3% 100% 3
4 COLON CANCER XENOGRAFT authKW 730905 3% 75% 3
5 A33 authKW 676759 5% 42% 5
6 KRN330 authKW 649694 2% 100% 2
7 MONOCLONAL ANTIBODY A33 authKW 649694 2% 100% 2
8 ANTI LEY ANTIBODY authKW 433128 2% 67% 2
9 HU3S193 authKW 433128 2% 67% 2
10 A33 ANTIBODY authKW 365449 3% 38% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 1045 54% 0% 51
2 Radiology, Nuclear Medicine & Medical Imaging 163 17% 0% 16
3 Biochemical Research Methods 16 5% 0% 5
4 Pathology 15 4% 0% 4
5 Biophysics 13 5% 0% 5
6 Biochemistry & Molecular Biology 9 13% 0% 12
7 Genetics & Heredity 8 5% 0% 5
8 Biotechnology & Applied Microbiology 8 5% 0% 5
9 Medicine, Research & Experimental 6 4% 0% 4
10 Pharmacology & Pharmacy 4 6% 0% 6

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOINT ONCOL UNIT 324847 1% 100% 1
2 KLIN HAMATOL ONKOL TRANSFUSIONS MED CBF 324847 1% 100% 1
3 MED KLIN 3 HEMATOL ONCOL TRANSFUS MED 324847 1% 100% 1
4 TUMOUR TARGETING PROGRAM 236246 4% 18% 4
5 NEW YORK BRANCH 150579 12% 4% 11
6 MELBOURNE BRANCH 145012 5% 9% 5
7 HEMATOPOIET CANC IMMUNOCHEM 108281 1% 33% 1
8 RADIOIMMUNE INORGAN CHEM SECT 96456 7% 4% 7
9 LUDWIG CANC 84631 33% 1% 31
10 TUMORMED 81210 1% 25% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DIAGNOSTIC ONCOLOGY 3417 1% 1% 1
2 EJNMMI RESEARCH 2963 2% 0% 2
3 EUROPEAN JOURNAL OF ONCOLOGY 2618 1% 1% 1
4 JOURNAL OF NUCLEAR MEDICINE 2045 9% 0% 8
5 CLINICAL CANCER RESEARCH 1068 7% 0% 7
6 GENES CHROMOSOMES & CANCER 919 3% 0% 3
7 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 888 2% 0% 2
8 CLINICAL & EXPERIMENTAL METASTASIS 648 2% 0% 2
9 IMMUNOTHERAPY 449 1% 0% 1
10 JOURNAL OF BIOPHOTONICS 432 1% 0% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 A33 ANTIGEN 1353528 5% 83% 5 Search A33+ANTIGEN Search A33+ANTIGEN
2 ADHESION REGULATING MOLECULE 1 974542 3% 100% 3 Search ADHESION+REGULATING+MOLECULE+1 Search ADHESION+REGULATING+MOLECULE+1
3 ADRM1 974542 3% 100% 3 Search ADRM1 Search ADRM1
4 COLON CANCER XENOGRAFT 730905 3% 75% 3 Search COLON+CANCER+XENOGRAFT Search COLON+CANCER+XENOGRAFT
5 A33 676759 5% 42% 5 Search A33 Search A33
6 KRN330 649694 2% 100% 2 Search KRN330 Search KRN330
7 MONOCLONAL ANTIBODY A33 649694 2% 100% 2 Search MONOCLONAL+ANTIBODY+A33 Search MONOCLONAL+ANTIBODY+A33
8 ANTI LEY ANTIBODY 433128 2% 67% 2 Search ANTI+LEY+ANTIBODY Search ANTI+LEY+ANTIBODY
9 HU3S193 433128 2% 67% 2 Search HU3S193 Search HU3S193
10 A33 ANTIBODY 365449 3% 38% 3 Search A33+ANTIBODY Search A33+ANTIBODY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DAUER, LT , BOYLAN, DC , WILLIAMSON, MJ , GERMAIN, JS , LARSON, SM , (2009) CLEARANCE KINETICS AND EXTERNAL DOSIMETRY OF I-131-LABELED MURINE AND HUMANIZED MONOCLONAL ANTIBODY A33 IN PATIENTS WITH COLON CANCER: RADIATION SAFETY IMPLICATIONS.HEALTH PHYSICS. VOL. 96. ISSUE 5. P. 550 -557 15 71% 1
2 BAPTISTELLA, AR , DIAS, MVS , AGUIAR, S , BEGNAMI, MD , MARTINS, VR , (2016) HETEROGENEOUS EXPRESSION OF A33 IN COLORECTAL CANCER: POSSIBLE EXPLANATION FOR A33 ANTIBODY TREATMENT FAILURE.ANTI-CANCER DRUGS. VOL. 27. ISSUE 8. P. 734 -737 12 75% 0
3 ZANZONICO, P , CARRASQUILLO, JA , PANDIT-TASKAR, N , O'DONOGHUE, JA , HUMM, JL , SMITH-JONES, P , RUAN, S , DIVGI, C , SCOTT, AM , KEMENY, NE , ET AL (2015) PET-BASED COMPARTMENTAL MODELING OF I-124-A33 ANTIBODY: QUANTITATIVE CHARACTERIZATION OF PATIENT-SPECIFIC TUMOR TARGETING IN COLORECTAL CANCER.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 42. ISSUE 11. P. 1700 -1706 14 61% 0
4 O'DONOGHUE, JA , SMITH-JONES, PM , HUMM, JL , RUAN, ST , PRYMA, DA , JUNGBLUTH, AA , DIVGI, CR , CARRASQUILLO, JA , PANDIT-TASKAR, N , FONG, YM , ET AL (2011) I-124-HUA33 ANTIBODY UPTAKE IS DRIVEN BY A33 ANTIGEN CONCENTRATION IN TISSUES FROM COLORECTAL CANCER PATIENTS IMAGED BY IMMUNO-PET.JOURNAL OF NUCLEAR MEDICINE. VOL. 52. ISSUE 12. P. 1878-1885 15 45% 14
5 CIPROTTI, M , CHONG, G , GAN, HK , CHAN, A , MURONE, C , MACGREGOR, D , LEE, FT , JOHNS, TG , HEATH, JK , ERNST, M , ET AL (2014) QUANTITATIVE INTRATUMOURAL MICRODISTRIBUTION AND KINETICS OF I-131-HUA33 ANTIBODY IN PATIENTS WITH COLORECTAL CARCINOMA.EJNMMI RESEARCH. VOL. 4. ISSUE . P. 1 -10 15 39% 3
6 SAKAMOTO, J , ORIUCHI, N , MOCHIKI, E , ASAO, T , SCOTT, AM , HOFFMAN, EW , JUNGBLUTH, AA , MATSUI, T , LEE, FT , PAPENFUSS, A , ET AL (2006) A PHASE I RADIOIMMUNOLOCALIZATION TRIAL OF HUMANIZED MONOCLONAL ANTIBODY HUA33 IN PATIENTS WITH GASTRIC CARCINOMA.CANCER SCIENCE. VOL. 97. ISSUE 11. P. 1248-1254 14 48% 10
7 WELT, S , RITTER, G , WILLIAMS, C , COHEN, LS , JOHN, M , JUNGBLUTH, A , RICHARDS, EA , OLD, LJ , KEMENY, NE , (2003) PHASE I STUDY OF ANTICOLON CANCER HUMANIZED ANTIBODY A33.CLINICAL CANCER RESEARCH. VOL. 9. ISSUE 4. P. 1338-1346 16 43% 51
8 BENDELL, JC , LENZ, HJ , RYAN, T , EL-RAYES, BF , MARSHALL, JL , MODIANO, MR , HART, LL , KINGSLEY, CD , GEORGE, TJ , NAKASHIMA, D , ET AL (2014) PHASE 1/2 STUDY OF KRN330, A FULLY HUMAN ANTI-A33 MONOCLONAL ANTIBODY, PLUS IRINOTECAN AS SECOND-LINE TREATMENT FOR PATIENTS WITH METASTATIC COLORECTAL CANCER.INVESTIGATIONAL NEW DRUGS. VOL. 32. ISSUE 4. P. 682 -690 11 48% 4
9 CARRASQUILLO, JA , PANDIT-TASKAR, N , O'DONOGHUE, JA , HUMM, JL , ZANZONICO, P , SMITH-JONES, PM , DIVGI, CR , PRYMA, DA , RUAN, ST , KEMENY, NE , ET AL (2011) I-124-HUA33 ANTIBODY PET OF COLORECTAL CANCER.JOURNAL OF NUCLEAR MEDICINE. VOL. 52. ISSUE 8. P. 1173-1180 13 39% 30
10 SCOTT, AM , LEE, FT , JONES, R , HOPKINS, W , MACGREGOR, D , CEBON, JS , HANNAH, A , CHONG, G , U, P , PAPENFUSS, A , ET AL (2005) A PHASE I TRIAL OF HUMANIZED MONOCLONAL ANTIBODY A33 IN PATIENTS WITH COLORECTAL CARCINOMA: BIODISTRIBUTION, PHARMACOKINETICS, AND QUANTITATIVE TUMOR UPTAKE.CLINICAL CANCER RESEARCH. VOL. 11. ISSUE 13. P. 4810-4817 14 40% 67

Classes with closest relation at Level 1


Rank Class id link
1 28336 RADIOIODINATION//PROSTHETIC RADIOIODINATION//ELED COMPOUND
2 411 RADIOIMMUNOTHERAPY//ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//IMMUNOSCINTIGRAPHY
3 18119 PRETARGETING//PRETARGETED RADIOIMMUNOTHERAPY//MOL MED IMMUNOL
4 11850 AT 211//ASTATINE//TARGETED ALPHA THERAPY
5 13646 AFFIBODY MOLECULE//AFFIBODY//BIOMED RADIAT SCI
6 15894 AUGER ELECTRONS//AUGER ELECTRON EMITTERS//CELLULAR DOSIMETRY
7 11281 ANTIBODY DRUG CONJUGATE//GEMTUZUMAB OZOGAMICIN//MYLOTARG
8 14540 ADEPT//NITROREDUCTASE//CB1954
9 12872 EPCAM//TROP2//EP CAM
10 11640 FUCOSYLTRANSFERASE//FUT2//ALPHA 1 2 FUCOSYLTRANSFERASE

Go to start page